Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia

Miloslav Beran*, Elihu Estey, Susan O'Brien, Jorge Cortes, Charles A. Koller, Francis J. Giles, Steven Kornblau, Michael Andreeff, Norbert Vey, Sherry R. Pierce, Kimberly Hayes, Gee Chuan Wong, Michael Keating, Hagop Kantarjian

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

123 Scopus citations

Fingerprint

Dive into the research topics of 'Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences